StreetAlpha
Taysha Gene Therapies, Inc. · SEC Form 4

TSHA Insider Trading

From SEC Form 412 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Taysha Gene Therapies, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $6.7M sold.

← TSHA stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$6.7M8 sales · 3 insiders
Net−$6.7Mbought minus sold
Planned sales46%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $1.7MDec2026-01: sold $2.8MJan2026-02: sold $7KFebMar2026-04: sold $892KAprMayJun2026-07: sold $1.2MJulAugSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when TSHA insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an TSHA officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every TSHA insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Jul 10, 2026Sukumar NagendranPresident and Head of R&DSale plan200,000$6.24$1.2M936,410Jul 10Form 4
Apr 10, 2026Sukumar NagendranPresident and Head of R&DSale plan200,000$4.46$892K1,136,410Apr 13Form 4
Feb 4, 2026Kamran AlamCFOSale1,655$4.52$7K1,442,131Feb 6Form 4
Jan 26, 2026Sean P. NolanCEOSale178,101$4.72$840K2,908,257Jan 27Form 4
Jan 26, 2026Sukumar NagendranPresident and Head of R&DSale116,050$4.72$547K1,317,389Jan 27Form 4
Jan 26, 2026Kamran AlamCFOSale102,817$4.72$485K1,443,786Jan 27Form 4
Jan 12, 2026Sukumar NagendranPresident and Head of R&DSale plan200,000$4.71$942K1,006,439Jan 14Form 4
Dec 1, 2025Sukumar NagendranPresident and Head of R&DSale370,172$4.58$1.7M1,006,439Dec 1Form 4
Sep 10, 2025Sukumar NagendranPresident and Head of R&DSale plan200,000$3.23$646K1,006,439Sep 12Form 4
Aug 21, 2025Kamran AlamCFOSale54,491$2.85$155K1,187,603Aug 22Form 4
Aug 21, 2025Sukumar NagendranPresident and Head of R&DSale57,054$2.85$163K1,165,289Aug 22Form 4
May 30, 2025Paul B Manning10% ownerBuy750,000$2.75$2.1M2,841,704Jun 3Form 4

TSHA insider trading FAQ

Are TSHA insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of TSHA on the open market in 0 trades, and 3 sold $6.7M in 8 trades, 46% of that under pre-arranged trading plans.

When did an TSHA insider last buy shares?

Paul B Manning (10% owner) bought 750,000 shares for $2.1M on May 30, 2025, reported on Jun 3, 2025.

When did an TSHA insider last sell shares?

Sukumar Nagendran (President and Head of R&D) sold 200,000 shares for $1.2M on Jul 10, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice